Evidence map›Paper›PMID 35024002›Full record

ArticleCrystal growth & design2022

Secondary Nucleation by Interparticle Energies. II. Kinetics.

Byeongho Ahn, Luca Bosetti, Marco Mazzotti

Open access · greenAbstract read
In one paragraph

Article in Crystal growth & design, 2022. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 8 papers.

0numbers the graph read from it
0cells of the map it votes in
8citing papers in PubMed
1.5field-weighted citation impact, top 18% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

8 citing papers in PubMed, 27 citations in OpenAlex.

  1. Review
  2. Article
  3. Article
  4. Article
  5. Article
  6. Article
  7. Article
  8. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

3 authors at 1 institution in 1 country.

Byeongho AhnInstitute of Energy and Process Engineering, ETH Zurich, Zurich 8092, Switzerland.ORCID https://orcid.org/0000-0002-4405-5041
Luca BosettiInstitute of Energy and Process Engineering, ETH Zurich, Zurich 8092, Switzerland.ORCID https://orcid.org/0000-0001-6657-6510
Marco MazzottiInstitute of Energy and Process Engineering, ETH Zurich, Zurich 8092, Switzerland.ORCID https://orcid.org/0000-0002-4948-6705
ETH Zurich · CH

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

This work presents a mathematical model that describes growth, homogeneous nucleation, and secondary nucleation that is caused by interparticle interactions between seed crystals and molecular clusters in suspension. The model is developed by incorporating the role of interparticle energies into a kinetic rate equation model, which yields the time evolution of nucleus and seed crystal populations, as in a population balance equation model, and additionally that of subcritical molecular clusters, thus revealing an important role of each population in crystallization. Seeded batch crystallization at a constant temperature has been simulated to demonstrate that the interparticle interactions increase the concentration of the critical clusters by several orders of magnitude, thus causing secondary nucleation. This explains how secondary nucleation can occur at a low supersaturation that is insufficient to trigger primary nucleation. Moreover, a sensitivity analysis has shown that the intensity of the interparticle energies has a major effect on secondary nucleation, while its effective distance has a minor effect. Finally, the simulation results are qualitatively compared with experimental observations in the literature, thus showing that the model can identify operating conditions at which primary or secondary nucleation is more prone to occur, which can be used as a useful tool for process design.

Identifiers

PMID35024002
PMCPMC8739839
OpenAlexW3215772689

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC-ND
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.